Podcast, News & Publications
Peace in strength. Like the mighty oak that has survived some 600 years in what is now my back yard, we engage with experience and resilience. Whether the winds blow hard or the sun shines bright, we go on, deeply rooted and stretching for the heavens.
Strength in peace. Many challenges of the world, and Pharmaceutical R&D, grow out of mere misunderstandings. We seek to enhance mutual understanding and peaceful cooperation toward shared objectives.
- Peace and Strength by Kevin Freiert
Salem Oaks Presents: a podcast sharing the human stories behind the medicines
This month listen to Dr. Carol Marzetta talk about how the urge to help other people has shaped her career and her life. From her earliest days as a Discovery Biologist, she has found her passion in work that tries to help people in need. She shares with us some stories about…Read More
We’ve all been there. You are at a party and someone asks, “So, what do you do?” Dr. Kirsch always found it hard to explain his career as a discovery scientist. He decided to write a book about it. The Drug Hunters: An Improbable Quest to Discover New Medicines is a colorful, fact-filled narrative history of…Read More
David Pearce Ph.D., Sanford Research Leader Today we hear from David Pearce, PhD, President of Innovation and Research, Sanford Health and Vice Chair, Consortium Assembly, International Rare Disease Research Consortium (IRDiRC) Dr. Pearce’s rare disease background emanates from publishing over 100 research papers on Batten Disease. David talks to us about…Read More
We welcome Kyle Bryant of the Friedreich’s Ataxia Research Alliance (FARA) to discuss his journey as a patient with Friedreich’s Ataxia (FA), as an active patient leader, and in his job as a liaison between the FA community and researchers. After being diagnosed with FA when only 17 years old,…Read More
Chasing My Cure: A Doctor’s Race to Turn Hope Into Action We are honored to have Dr. David Fajgenbaum as our first guest on Improbable Developments. His story is intense. Before he even earned is medical degree, he was faced by a rare life-threatening illness for which there was no…Read More
News & Publications
Let’s do a quick word association exercise. What is the first word that comes to mind when you read each of the terms below? Trial Investigator Subject Attrition Arms Targets Chances are your responses were somehow affected by your level of familiarity with medicines development. Introduction Patients are the most important…Read More
Introduction Patients are the most important stakeholders in the development of new therapies. Thus, one might conclude that patients must be involved in the process of developing these therapies. While there are some excellent examples of patient involvement improving both the execution and the focus of clinical trials, it is far from the…Read More